ESC 365 - Reversal strategies and outcomes of major bleeding associated with direct oral anticoagulants compared to warfarin in routine practice: interim results from a multi-centre all-comer cohort

ESC Premium Access

Reversal strategies and outcomes of major bleeding associated with direct oral anticoagulants compared to warfarin in routine practice: interim results from a multi-centre all-comer cohort

Session: Antithrombotic therapy in atrial fibrillation 2

Topic: Atrial fibrillation (AF)

Speaker: Doctor Y. Xu (Toronto, CA)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Yan Xu

University of Toronto, Toronto (Canada)

0 follower

4 more presentations in this session

Validation of a Modified CHA2DS2-VASc score for stroke risk Stratification in Asian patients with qtrial fibrillation

Speaker: Doctor T. Chao (Taipei, TW)

Temporal change of anticoagulation therapy and its outcomes of Japanese atrial fibrillation patients in the real-world clinical practice: the Fushimi AF Registry.

Speaker: Doctor M. Akao (Kyoto, JP)

Hospitalization-related costs among patients with atrial fibrillation treated with the factor Xa inhibitor edoxaban vs warfarin: results from the ENGAGE AF-TIMI 48 trial

Speaker: Professor E. Magnuson (Kansas City, US)

Vitamin K antagonist control for patients with nonvalvular atrial fibrillation in Eastern and Southeastern Asia: an analysis of event rates from GARFIELD-AF

Speaker: Professor S. Goto (Isehara, JP)

Access the full session

Antithrombotic therapy in atrial fibrillation 2

Speakers: Doctor Y. Xu, Doctor T. Chao, Doctor M. Akao, Professor E. Magnuson, Professor S. Goto

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources